Suppr超能文献

雄激素与雌激素受体和前列腺癌临床形态学特征之间的关系

[Relationship between androgen and estrogen receptors and clinico-morphological characteristics of prostatic cancer].

作者信息

Bassalyk L S, Petrova A S, Ermilova V D, Sokolova V K, Kushlinskiĭ N E

出版信息

Arkh Patol. 1983;45(2):23-8.

PMID:6847409
Abstract

The paper presents the results of studies on cytoplasmic receptors of androgens (AR) and estrogens (ER) in tumors of 50 patients with prostate carcinoma with respect to age, histological structure and degree of tumor differentiation, and stage of the disease. The study showed the majority of tumors in patients not previously treated with estrogens to contain one or both types of receptors. In prostate carcinoma AR were found more frequently and both receptors were present twice as frequently in elderly as compared to senile patients. In the latter, adenocarcinomas containing only ER were predominant. AR could be detected more frequently in highly differentiated than in poorly differentiated tumors. ER did not correlate with the histological structure and degree of differentiation of the tumor. A negative correlation was observed between the stage of the tumor progression and the presence of AR in prostate carcinoma. AR and ER were seldom found in tumors of the patients treated with estrogens for a long time. Among 13 patients who died from advanced tumor, no AR were found in 12 tumors, both receptors were present in 1 tumor, and ER alone in 5 tumors.

摘要

本文介绍了对50例前列腺癌患者肿瘤中雄激素受体(AR)和雌激素受体(ER)的研究结果,研究涉及患者年龄、组织学结构、肿瘤分化程度及疾病分期。研究表明,大多数未曾接受过雌激素治疗的患者肿瘤中含有一种或两种类型的受体。在前列腺癌中,AR的发现频率更高,且与老年患者相比,两种受体在老年患者中的出现频率是老年前期患者的两倍。在老年前期患者中,仅含ER的腺癌占主导。高分化肿瘤中AR的检测频率高于低分化肿瘤。ER与肿瘤的组织学结构和分化程度无关。前列腺癌中肿瘤进展阶段与AR的存在呈负相关。长期接受雌激素治疗的患者肿瘤中很少发现AR和ER。在13例死于晚期肿瘤的患者中,12个肿瘤未发现AR,1个肿瘤同时存在两种受体,5个肿瘤仅存在ER。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验